Head-to-head comparisons of medication uses, side effects, warnings, and more.
Ocrevus (ocrelizumab)
Ocrevus zunovo
Ocrevus (ocrelizumab)
Ocrevus zunovo
Summary of Ocrevus vs. Ocrevus Zunovo
Summary for Monoclonal antibody
Prescription only
Ocrevus (ocrelizumab) is used to treat multiple sclerosis (MS) in adults. It's a type of medication called a monoclonal antibody. It's given as an infusion through the vein every 6 months at a medical center or clinic. A trained healthcare professional will help give Ocrevus (ocrelizumab) to you. Side effects can include a higher risk of infections and infusion reactions.
Summary for Monoclonal antibody
Prescription only
Ocrevus Zunovo (ocrelizumab / hyaluronidase) is an injection that's given under the skin (subcutaneous). It's used to treat multiple sclerosis (MS) in adults. Ocrevus Zunovo is a monoclonal antibody. It also contains an enzyme called hyaluronidase that makes it easier for the medication to absorb through the skin. The injection is given every 6 months by a healthcare professional at a medical center or clinic. Side effects include injection-site reactions like pain, itching, and redness. You might also have a headache and feel nauseous.